As America’s first eye specialty hospital, founded in 1820, New York Eye and Ear Infirmary of Mount Sinai (NYEE) has made it its mission to enhance patient care through groundbreaking research and innovation that can be rapidly translated from bench to bedside. In this issue, we take a closer look at one of NYEE’s esteemed physicians, Paul Finger, MD, FACS, and his pioneering work in the field of ocular cancer, which has had a profound impact on current treatment modalities and their outcomes. In addition, NYEE continues to move forward in bringing robotic microsurgical interventions to the United States as the hospital comes closer to its first clinical trials in epiretinal membrane peeling.
Refer an Ophthalmology Patient
or call 212-979-4500.